Comparison of the rates of emergent otologic adverse events following mRNA COVID-19 versus influenza vaccination: a matched cohort analysis

Frontiers in neurology
 |
Tina Munjal, Shelley Batts, Saurabh Gombar, Konstantina M Stankovic
BACKGROUND: Otologic adverse events (AEs) have been occasionally reported as sequalae of COVID-19 vaccination, although their incidence in comparison with that of preexisting vaccines with high uptake remains unclear. This study compared the rates of new-onset otologic AEs among matched adults receiving mRNA COVID-19 vaccination versus influenza vaccination.